Journal of Clinical Lipidology Impact Factor Increases to 6.9

The National Lipid Association (NLA) is pleased to announce that the Journal of Clinical Lipidology (JCL), the Association’s official peer-reviewed journal, has achieved an Impact…

NLA Highlights New Meta-Analysis Supporting LDL-C Lowering in Primary Prevention

The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse…

Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association

This Expert Clinical Consensus provides redefined diagnostic criteria, updated ICD-10 codes, and guidance on genetic testing and cascade screening.

LDL-C Management Simplified in Adults

LDL Cholesterol Management Simplified in Adults—Lower for Longer is Better: Guidance from the National Lipid Association

The primary goals for LDL-C management are to achieve an acceptable level for the patient’s risk category and to maintain that over time.

Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care: A National Lipid Association Expert Clinical Review

Multidisciplinary care teams lead to improved lipid management and cardiometabolic health.

Managing Hypercholesterolemia in Adults Older Than 75 Years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society

Statins reduce ASCVD events in adults older than75 years without prior ASCVD.

Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology

Patients with persistent chylomicronemia and alarm features have a very high risk of acute pancreatitis, similar to FCS.